Mycophenolate Mofetil Potential First-Line Therapy in Juvenile Localized Scleroderma: JAMA
A new study published in the JAMA Dermatology found mycophenolate mofetil (MMF) treatment response comparable to methotrexate (MTX) in reducing disease activity in juvenile localized scleroderma (JLS). Flare rates were…